Med-Imaps-Plateforme Technologique d'Innovation Biomédicale (PTIB)-Hôpital Xavier Arnozan, CHU Bordeaux, Pessac, France.
Bone. 2010 Jan;46(1):176-81. doi: 10.1016/j.bone.2009.06.032. Epub 2009 Sep 10.
The trabecular bone score (TBS) is a new parameter that is determined from grey level analysis of DXA images. It relies on the mean thickness and volume fraction of trabecular bone microarchitecture. This was a preliminary case-control study to evaluate the potential diagnostic value of TBS, both alone and combined with bone mineral density (BMDa), in the assessment of vertebral fracture.
Out of a subject pool of 441 Caucasian, postmenopausal women between the ages of 50 and 80 years, we identified 42 women with osteoporosis-related vertebral fractures, and compared them with 126 age-matched women without any fractures (1 case: 3 controls). Primary outcomes were BMDa and TBS. Inter-group comparisons were undertaken using Student's t-tests and Wilcoxon signed ranks tests for parametric and non-parametric data, respectively. Odds ratios for vertebral fracture were calculated for each incremental one standard deviation decrease in BMDa and TBS, and areas under the receiver operating curve (AUC) calculated and sensitivity analysis were conducted to compare BMDa alone, TBS alone, and the combination of BMDa and TBS. Subgroup analyses were performed specifically for women with osteopenia, and for women with T-score-defined osteoporosis.
Across all subjects (n=42, 126) weight and body mass index were greater and BMDa and TBS both less in women with fractures. The odds of vertebral fracture were 3.20 (95% CI, 2.01-5.08) for each incremental decrease in TBS, 1.95 (1.34-2.84) for BMDa, and 3.62 (2.32-5.65) for BMDa + TBS combined. The AUC was greater for TBS than for BMDa (0.746 vs. 0.662, p=0.011). At iso-specificity (61.9%) or iso-sensitivity (61.9%) for both BMDa and TBS, TBS + BMDa sensitivity or specificity was 19.1% or 16.7% greater than for either BMDa or TBS alone. Among subjects with osteoporosis (n=11, 40) both BMDa (p=0.0008) and TBS (p=0.0001) were lower in subjects with fractures, and both OR and AUC (p=0.013) for BMDa + TBS were greater than for BMDa alone (OR=4.04 [2.35-6.92] vs. 2.43 [1.49-3.95]; AUC=0.835 [0.755-0.897] vs. 0.718 [0.627-0.797], p=0.013). Among subjects with osteopenia, TBS was lower in women with fractures (p=0.0296), but BMDa was not (p=0.75). Similarly, the OR for TBS was statistically greater than 1.00 (2.82, 1.27-6.26), but not for BMDa (1.12, 0.56-2.22), as was the AUC (p=0.035), but there was no statistical difference in specificity (p=0.357) or sensitivity (p=0.678).
The trabecular bone score warrants further study as to whether it has any clinical application in osteoporosis detection and the evaluation of fracture risk.
骨小梁骨评分(TBS)是一种从 DXA 图像的灰度分析中确定的新参数。它依赖于骨小梁微结构的平均厚度和体积分数。这是一项初步的病例对照研究,旨在评估 TBS 单独以及与骨矿物质密度(BMDa)联合应用于评估椎体骨折的潜在诊断价值。
在 441 名 50 至 80 岁的绝经后白种人受试者中,我们确定了 42 名与骨质疏松相关的椎体骨折患者,并将其与 126 名年龄匹配的无骨折患者进行了比较(1 例:3 例对照)。主要结局是 BMDa 和 TBS。使用学生 t 检验和 Wilcoxon 符号秩检验分别对组间比较进行参数和非参数数据。计算每个 BMDa 和 TBS 标准差降低 1 个标准差时椎体骨折的比值比,并计算接收者操作特征曲线(AUC)下面积,并进行敏感性分析,以比较 BMDa 单独、TBS 单独和 BMDa 和 TBS 的联合应用。专门对骨质疏松症患者和 T 评分定义的骨质疏松症患者进行了亚组分析。
在所有受试者(n=42,126)中,骨折患者的体重和体重指数较大,BMDa 和 TBS 均较低。TBS 每降低 1 个标准差,椎体骨折的几率为 3.20(95%CI,2.01-5.08),BMDa 为 1.95(1.34-2.84),BMDa + TBS 为 3.62(2.32-5.65)。TBS 的 AUC 大于 BMDa(0.746 对 0.662,p=0.011)。在 BMDa 和 TBS 的特异性(61.9%)或敏感性(61.9%)相同的情况下,TBS+BMDa 的敏感性或特异性比 BMDa 或 TBS 单独提高了 19.1%或 16.7%。在骨质疏松症患者(n=11,40)中,骨折患者的 BMDa(p=0.0008)和 TBS(p=0.0001)均较低,BMDa + TBS 的 OR 和 AUC(p=0.013)均大于 BMDa 单独(OR=4.04 [2.35-6.92] 对 2.43 [1.49-3.95];AUC=0.835 [0.755-0.897] 对 0.718 [0.627-0.797],p=0.013)。在骨质疏松症患者中,TBS 在骨折患者中较低(p=0.0296),但 BMDa 则不然(p=0.75)。同样,TBS 的 OR 大于 1.00(2.82,1.27-6.26),但 BMDa 则不然(1.12,0.56-2.22),AUC 也是如此(p=0.035),但特异性(p=0.357)或敏感性(p=0.678)无统计学差异。
骨小梁骨评分值得进一步研究,以确定其在骨质疏松症检测和骨折风险评估中的临床应用价值。